GeneCards is a great source for in-depth information about genes, pathways and diseases. Combining that with BioCompare’s in-depth product coverage makes it easier for life scientists to uncover the right gene-specific tools for their research.
SAN FRANCISCO (PRWEB)
November 29, 2018
– Biocompare to begin offering its customers access to ads on the GeneCards website
LifeMap Sciences and Biocompare to begin data partnership for enriched product annotations to be offered to manufacturers
Biocompare, the leading product related information resource in the life sciences, and LifeMap Sciences, an industry leader in online biomedical databases, announced a strategic partnership today.
With this strategic partnership, Biocompare will start offering ad sales on the GeneCards website (http://www.genecards.org), making it simpler for marketers to reach scientists across both platforms through targeted display ads and email opportunities.
GeneCards, the Human Gene Database (http://www.genecards.org), offer detailed user-friendly information on all annotated and predicted human genes. Together with other biomedical databases offered by LifeMap Sciences, it caters to more than 4 million researchers world-wide and is used by more than 3,000 commercial and research institutions including top biotech pharma. GeneCards is developed at the Weizmann Institute of Science in Israel.
In addition, Biocompare and LifeMap Sciences will begin a data partnership that will offer life science manufacturers an easy solution for enhancing information on their products, including any gene, pathway, transcript, variant or disease specific products. This will make it easier for researchers to find the manufacturers’ products on search engines and to categorize products on manufacturers’ websites.
“We’re very excited about this partnership.” says Michael Okimoto, Ph.D., Chief Content Officer of Biocompare. “GeneCards is a great source for in-depth information about genes, pathways and diseases. Combining that with Biocompare’s in-depth product coverage makes it easier for life scientists to uncover the right gene-specific tools for their research.”
“Partnering with Biocompare will also allow us to enable researchers to have easier access to products that would help them in their research.” comments Yaron Golan, CEO of LifeMap Sciences, “The partnership between the two organizations will also create a powerful data solution for manufacturers, leveraging our annotated biomedical data, we can help life science vendors enrich their product data and improve outcomes in their own SEO and on-site marketing”.
This partnership will begin immediately; questions regarding any of the solutions mentioned above can be directed to Yaron Guan Golan, CEO at LifeMap Sciences, at yg(at)lifemapsc.com, or Joan Boyce, Vice President and General Manager of Biocompare, at jboyce(at)Biocompare.com.
Biocompare, a Division of CompareNetworks, Inc., is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative resource that enables them to make better product, technology, and service purchasing decisions. Produced by scientists, Biocompare’s mission is to provide free, time-saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education.
For more information, please visit https://www.Biocompare.com.
About LifeMap Sciences
LifeMap Sciences is a life sciences technology company that offers integrated, streamlined solutions that empower life scientists worldwide to conduct cutting-edge basic, clinical and applied biomedical research. LifeMap’s products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biopharma and diagnostic companies. Operations worldwide are carried out from our offices in California, Massachusetts, New Jersey, Tel Aviv, and Hong Kong. LifeMap is a subsidiary of AgeX Therapeutics, Inc.
For more information, please visit http://www.lifemapsc.com/.
About the Weizmann Institute of Science and GeneCards
The Weizmann Institute of Science in Rehovot, Israel, is one of the world’s top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to scientists, postdoctoral fellows, Ph.D. and M.Sc. students, and scientific, technical and administrative staff. In addition, visiting scientists and their families – over 500 from 35 countries are regularly hosted at the Institute. Particular excellence in bioinformatics and systems biology is manifested, among others, in the GeneCards project, initiated in 1996, under the leadership of Prof. Doron Lancet of the Dept. of Molecular Genetics, until recently Head of the Crown Human Genome Center. The team, led by Marilyn Safran, continuously innovates to maintain GeneCards as the leading integrated human gene compendium.
Share article on social media or email: